290 related articles for article (PubMed ID: 29307520)
1. Skeletal muscle ceramides and daily fat oxidation in obesity and diabetes.
Broskey NT; Obanda DN; Burton JH; Cefalu WT; Ravussin E
Metabolism; 2018 May; 82():118-123. PubMed ID: 29307520
[TBL] [Abstract][Full Text] [Related]
2. Muscle-Saturated Bioactive Lipids Are Increased with Aging and Influenced by High-Intensity Interval Training.
Søgaard D; Baranowski M; Larsen S; Taulo Lund M; Munk Scheuer C; Vestergaard Abildskov C; Greve Dideriksen S; Dela F; Wulff Helge J
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871020
[TBL] [Abstract][Full Text] [Related]
3. Ceramide content is higher in type I compared to type II fibers in obesity and type 2 diabetes mellitus.
Kristensen D; Prats C; Larsen S; Ara I; Dela F; Helge JW
Acta Diabetol; 2013 Oct; 50(5):705-12. PubMed ID: 22350135
[TBL] [Abstract][Full Text] [Related]
4. The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach.
Raichur S; Brunner B; Bielohuby M; Hansen G; Pfenninger A; Wang B; Bruning JC; Larsen PJ; Tennagels N
Mol Metab; 2019 Mar; 21():36-50. PubMed ID: 30655217
[TBL] [Abstract][Full Text] [Related]
5. Acetyl-CoA carboxylase 2 inhibition reduces skeletal muscle bioactive lipid content and attenuates progression of type 2 diabetes in Zucker diabetic fatty rats.
Takagi H; Ikehara T; Hashimoto K; Tanimoto K; Shimazaki A; Kashiwagi Y; Sakamoto S; Yukioka H
Eur J Pharmacol; 2021 Nov; 910():174451. PubMed ID: 34454928
[TBL] [Abstract][Full Text] [Related]
6. Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans.
Bergman BC; Brozinick JT; Strauss A; Bacon S; Kerege A; Bui HH; Sanders P; Siddall P; Kuo MS; Perreault L
Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E398-408. PubMed ID: 26126684
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of Ectopic Fat Deposition: The Next Frontier in Serum Lipidomics.
Perreault L; Starling AP; Glueck D; Brozinick JT; Sanders P; Siddall P; Kuo MS; Dabelea D; Bergman BC
J Clin Endocrinol Metab; 2016 Jan; 101(1):176-82. PubMed ID: 26574956
[TBL] [Abstract][Full Text] [Related]
8. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance.
Haus JM; Kashyap SR; Kasumov T; Zhang R; Kelly KR; Defronzo RA; Kirwan JP
Diabetes; 2009 Feb; 58(2):337-43. PubMed ID: 19008343
[TBL] [Abstract][Full Text] [Related]
9. Intramyocellular Ceramides: Subcellular Concentrations and Fractional De Novo Synthesis in Postabsorptive Humans.
Chung JO; Koutsari C; Blachnio-Zabielska AU; Hames KC; Jensen MD
Diabetes; 2017 Aug; 66(8):2082-2091. PubMed ID: 28483801
[TBL] [Abstract][Full Text] [Related]
10. Intracellular localization of diacylglycerols and sphingolipids influences insulin sensitivity and mitochondrial function in human skeletal muscle.
Perreault L; Newsom SA; Strauss A; Kerege A; Kahn DE; Harrison KA; Snell-Bergeon JK; Nemkov T; D'Alessandro A; Jackman MR; MacLean PS; Bergman BC
JCI Insight; 2018 Feb; 3(3):. PubMed ID: 29415895
[TBL] [Abstract][Full Text] [Related]
11. Skeletal muscle lipogenic protein expression is not different between lean and obese individuals: a potential factor in ceramide accumulation.
Thrush AB; Brindley DN; Chabowski A; Heigenhauser GJ; Dyck DJ
J Clin Endocrinol Metab; 2009 Dec; 94(12):5053-61. PubMed ID: 19837942
[TBL] [Abstract][Full Text] [Related]
12. MECHANISMS IN ENDOCRINOLOGY: Skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes: a causal mechanism or an innocent bystander?
Brøns C; Grunnet LG
Eur J Endocrinol; 2017 Feb; 176(2):R67-R78. PubMed ID: 27913612
[TBL] [Abstract][Full Text] [Related]
13. Effect of pioglitazone on plasma ceramides in adults with metabolic syndrome.
Warshauer JT; Lopez X; Gordillo R; Hicks J; Holland WL; Anuwe E; Blankfard MB; Scherer PE; Lingvay I
Diabetes Metab Res Rev; 2015 Oct; 31(7):734-44. PubMed ID: 25959529
[TBL] [Abstract][Full Text] [Related]
14. Fuel metabolism in adult individuals with a wide range of body mass index: effect of a family history of type 2 diabetes.
De Pergola G; Pannacciulli N; Minenna A; Martina RA; Cannito F; Giorgino R
Diabetes Nutr Metab; 2003 Feb; 16(1):41-7. PubMed ID: 12848304
[TBL] [Abstract][Full Text] [Related]
15. Role of skeletal muscle lipids in the pathogenesis of insulin resistance of obesity and type 2 diabetes.
Gilbert M
J Diabetes Investig; 2021 Nov; 12(11):1934-1941. PubMed ID: 34132491
[TBL] [Abstract][Full Text] [Related]
16. Plasma ceramides are elevated in female children and adolescents with type 2 diabetes.
Lopez X; Goldfine AB; Holland WL; Gordillo R; Scherer PE
J Pediatr Endocrinol Metab; 2013; 26(9-10):995-8. PubMed ID: 23612696
[TBL] [Abstract][Full Text] [Related]
17. Skeletal muscle ceramide species in men with abdominal obesity.
de la Maza MP; Rodriguez JM; Hirsch S; Leiva L; Barrera G; Bunout D
J Nutr Health Aging; 2015 Apr; 19(4):389-96. PubMed ID: 25809802
[TBL] [Abstract][Full Text] [Related]
18. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites.
Lee JS; Pinnamaneni SK; Eo SJ; Cho IH; Pyo JH; Kim CK; Sinclair AJ; Febbraio MA; Watt MJ
J Appl Physiol (1985); 2006 May; 100(5):1467-74. PubMed ID: 16357064
[TBL] [Abstract][Full Text] [Related]
19. Targeting ceramide metabolism in obesity.
Aburasayn H; Al Batran R; Ussher JR
Am J Physiol Endocrinol Metab; 2016 Aug; 311(2):E423-35. PubMed ID: 27382035
[TBL] [Abstract][Full Text] [Related]
20. Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells.
Bandet CL; Tan-Chen S; Bourron O; Le Stunff H; Hajduch E
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
